Web Results


Oct 9, 2012 ... B. The Relators listed herein have filed the following quitam actions against Pfizer. (collectively the “Civil Actions"):. (1) United States et al. ex rel. Blair Collins v. Pfizer, Inc.,. Civ. No. 04-11780-DPW (D. Mass.); (2) United States et al. ex rel. John Kopchinski v. Pfizer, Inc. et al.,. Civ. No. 05-CV-12115 (D. Mass.); ...


Nov 16, 2017 ... The petitioner, M.M., an infant, by her mother, is one of nineteen minor plaintiffs who alleged that they sustained birth defects from their mother's use of the prescription anti-depressant Zoloft. The respondent, Pfizer, manufactures and markets Zoloft. The remaining respondents, Roerig and Greenhouse, are ...


Jan 28, 2015 ... Pfizer Inc., et al., No. 10-3864, S.D. N.Y.; See August 2010, Page 38). According to the company's SEC Form 8-K, Pfizer reported “higher charges for certain legal matters, primarily reflecting a $400 million charge for an agreement in principle to resolve a securities class action pending against the company ...


Boorman et al., 1990. G.A. Boorman, S.L. Eustis, M.R. Elwell, et al.Pathology of the Fischer rat. Reference and atlas, Academic Press, San Diego New York, London (1990), pp ... Keenan et al., 2002. C. Keenan, A. Hughes-Earle, M. Case, et al.The North American Control Animal Database: a resource based on standardized ...


Nov 1, 2017 ... Inc., et al., Civil Action No. 9250-VCG ... 1 Garner v. Wolfinbarger, 430 F.2d 1093 (5th Cir. 1970). 2 A more detailed description of the allegations in the Complaint can be found in my decision on ..... claim is established by Judge Keenan's December 21, 1990 denial of a motion to dismiss for failure to state a ...


Mar 25, 2011 ... However, concerns still exist due to the paradoxical effects of pulsatile versus sustained elevations in PTH that have been associated with bone formation ..... Van Wagenen BC, Del Mar EG, Sheehan D, Barmore RM, Keenan RM, Kotecha NR, et al., inventors; Calcilytic Compounds patent WO 97/37967 A1.


Alm-Roijer et al (2004), showed statistically significant correlations between patients' general knowledge about coronary heart disease (CHD) risk factors and improvements in weight ..... Proceedings of Pfizer conference: Promoting health literacy: a call to action; October 7–8, 1998; Washington, DC: Pfizer, Inc.; 1998. pp.


Apr 20, 2017 ... This opinion piece was prepared by PME, PJH, and VS in their personal capacity. ... Without a clear understanding of the scale of the problem, the pharmaceutical company Pfizer Inc. agreed to an initial donation of 10 million doses of its .... Porco TC, Gebre T, Ayele B, House J, Keenan J, Zhou Z, et al.